These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21029745)

  • 21. Effects of Botox and Neuronox on muscle force generation in mice.
    Stone AV; Ma J; Whitlock PW; Koman LA; Smith TL; Smith BP; Callahan MF
    J Orthop Res; 2007 Dec; 25(12):1658-64. PubMed ID: 17600825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-term effects of botulinum toxin on the lateral rectus muscle of the cat.
    Dimitrova DM; Shall MS; Goldberg SJ
    Exp Brain Res; 2002 Dec; 147(4):449-55. PubMed ID: 12444476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of ethanol on neuromuscular function in the rat diaphragm preparation.
    Wali FA; Hayter AP
    Alcohol Alcohol; 1988; 23(4):299-303. PubMed ID: 2844197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lectins from Triticum vulgaris and Limax flavus are universal antagonists of botulinum neurotoxin and tetanus toxin.
    Bakry N; Kamata Y; Simpson LL
    J Pharmacol Exp Ther; 1991 Sep; 258(3):830-6. PubMed ID: 1653841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative study of biological activity of four botulinum toxin type A preparations in mice.
    Chung ME; Song DH; Park JH
    Dermatol Surg; 2013 Jan; 39(1 Pt 2):155-64. PubMed ID: 23301819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GDNF overexpression fails to provoke muscle recovery from botulinum toxin poisoning: a preliminary study.
    Lin KF; Sun HH; Macewan MR; Mackinnon SE; Johnson PJ
    Microsurgery; 2012 Jul; 32(5):370-6. PubMed ID: 22473739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study of in vitro and in vitro effects of isradipine in skeletal muscles and interaction with some drugs.
    Singh YN; Johnson A; Lulf LA; Singh BN
    Methods Find Exp Clin Pharmacol; 1996 Oct; 18(8):499-506. PubMed ID: 9044237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacology of botulinum neurotoxin type A].
    Bigalke H
    Wien Klin Wochenschr; 2001; 113 Suppl 4():2-5. PubMed ID: 15506044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased efficacy and decreased systemic-effects of botulinum toxin A injection after active or passive muscle manipulation.
    Minamoto VB; Hulst JB; Lim M; Peace WJ; Bremner SN; Ward SR; Lieber RL
    Dev Med Child Neurol; 2007 Dec; 49(12):907-14. PubMed ID: 18039237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Botulinum toxin in gastric submucosa reduces stimulated HCl production in rats.
    Runfola M; Rossi S; Panunzi S; Spada PL; Gui D
    BMC Gastroenterol; 2003 Sep; 3():26. PubMed ID: 12964945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term effects of botulinum toxin on neuromuscular function.
    Frick CG; Richtsfeld M; Sahani ND; Kaneki M; Blobner M; Martyn JA
    Anesthesiology; 2007 Jun; 106(6):1139-46. PubMed ID: 17525589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pharmacodynamic comparison study of different botulinum toxin type A preparations.
    Kim SB; Ban B; Jung KS; Yang GH
    Dermatol Surg; 2013 Jan; 39(1 Pt 2):150-4. PubMed ID: 23301818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A single injection of botulinum toxin decreases the margin of safety of neurotransmission at local and distant sites.
    Frick CG; Fink H; Blobner M; Martyn J
    Anesth Analg; 2012 Jan; 114(1):102-9. PubMed ID: 22003222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of neuromuscular-blocking drugs in rats in vivo: direct measurements in the diaphragm and tibialis anterior muscle.
    Itoh H; Shibata K; Matsumoto T; Nitta S; Nishi M; Kobayashi T; Yamamoto K
    Acta Anaesthesiol Scand; 2004 Aug; 48(7):903-8. PubMed ID: 15242438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of biological activity of commercially available purified native botulinum neurotoxin serotypes A1 to F1 in vitro, ex vivo, and in vivo.
    Donald S; Elliott M; Gray B; Hornby F; Lewandowska A; Marlin S; Favre-Guilmard C; Périer C; Cornet S; Kalinichev M; Krupp J; Fonfria E
    Pharmacol Res Perspect; 2018 Dec; 6(6):e00446. PubMed ID: 30519475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of botulinum toxin A on functional outcome during distraction osteogenesis.
    Olabisi R; Best TM; Vanderby R; Petr S; Noonan KJ
    J Orthop Res; 2007 May; 25(5):656-64. PubMed ID: 17262822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polyclonal neural cell adhesion molecule antibody prolongs the effective duration time of botulinum toxin in decreasing muscle strength.
    Guo Y; Pan L; Liu W; Pan Y; Nie Z; Jin L
    Neurol Sci; 2015 Nov; 36(11):2019-25. PubMed ID: 26150164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuromuscular activity of BaTX, a presynaptic basic PLA2 isolated from Bothrops alternatus snake venom.
    Ponce-Soto LA; Barros JC; Marangoni S; Hernandez S; Dal Belo CA; Corrado AP; Hyslop S; Rodrigues-Simioni L
    Comp Biochem Physiol C Toxicol Pharmacol; 2009 Aug; 150(2):291-7. PubMed ID: 19463969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does vitamin B alter the efficacy of botulinum toxin?
    Tatlidede S; Baslo MB; Özkaya Ö; Soydan T; Orhan EK; Yeşilada AK
    Aesthetic Plast Surg; 2012 Jun; 36(3):692-7. PubMed ID: 22395300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Globular chitosan prolongs the effective duration time and decreases the acute toxicity of botulinum neurotoxin after intramuscular injection in rats.
    Sergeevichev DS; Krasilnikova AA; Strelnikov AG; Fomenko VV; Salakhutdinov NF; Romanov AB; Karaskov AM; Pokushalov EA; Steinberg JS
    Toxicon; 2018 Mar; 143():90-95. PubMed ID: 29371111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.